OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic ...
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the ...
Aldeyra Therapeutics Is Severely Undervalued Before PDUFA
Aldeyra's reproxalap faced an FDA setback but showed positive trial results, leading to a resubmitted NDA. Click here to find ...